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Many articles about memory   reconsolidation 
conclude with its therapeutic implications 
for posttraumatic stress disorder (PTSD). 
A core feature of PTSD is the memory of 
a traumatic event that is characterized by 
excessive strength, immalleability, and per-
sistence. We found that Korean and World 
War II veterans with PTSD showed elevated 
physiological  responses  during  mental 
imagery of their personal combat events as 
long as 40 years later (Orr et al., 1993). We 
have hypothesized that traumatic memo-
ries in PTSD become “overconsolidated” 
under  the  influence  of  stress  hormones 
stimulated by the traumatic event (Pitman, 
1989). Traditional theory holds that once a 
memory has been consolidated, i.e., placed 
into long-term storage, it exists as a perma-
nent trace. According to this view, the most 
one can hope for therapeutically would be 
to inhibit the memory’s expression through 
a mechanism such as extinction, but this 
inhibition is fragile, and the associated dis-
tress and arousal may return. Years ago we 
consulted on the case of a veteran who was 
admitted to the hospital for low back pain. 
Following World War II, he had experienced 
a year of nightmares and flashbacks of his 
combat experiences. With time these symp-
toms remitted, and he had been symptom 
free for 30 years. The medical work-up for 
his back pain revealed carcinoma of the 
prostate metastatic to the vertebrae, a fatal 
condition. The night after the patient was 
presented with this diagnosis, he experi-
enced nightmares, not of his cancer or its 
future consequences, but of combat. This 
reinstatement of his combat memories by 
the stress of his cancer diagnosis indicated 
that they had not been erased but only had 
become latent.
Recent animal research has challenged 
the permanence of consolidated memory 
traces  by  suggesting  that  reactivation 
(retrieval) of a memory can return it to an 
unstable state from which it must be “re-
consolidated” if it is to persist. Blocking 
reconsolidation offers the therapeutic pos-
sibility of weakening traumatic memories 
in  PTSD. A  recent  Pavlovian  differential 
conditioning  study  in  normal  humans 
employed memory reactivation accompa-
nied by the beta-adrenergic blocker pro-
pranolol  (Kindt  et  al.,  2009).  After  that 
intervention, the previously acquired con-
ditioned stimulus (CS) could no longer be 
made to elicit a skin conductance response. 
In contrast, the declarative memory of the 
contingency survived, suggesting that only 
the  memory’s  fear  component  had  been 
erased – an ideal scenario from the clinical 
standpoint. Another recent normal human 
conditioning study substituted a behavio-
ral intervention (Schiller et al., 2010) and 
used potentiated startle as the measure of 
fear. A single CS trial was followed by a 
10-min delay, and then by further extinc-
tion trials. Following this intervention, the 
conditioned fear response was not merely 
inhibited but permanently eliminated. It 
was argued that the delay provided suffi-
cient time for the reactivated fear memory 
trace to return to an unstable state, so that 
the remaining CS presentations occurred 
during  a “reconsolidation  window.”  This 
allowed  the  original  fear  memory  to  be 
modified or “updated” to incorporate the 
new information that the CS was no longer 
dangerous. The investigators suggested that 
such a delay tactic could be incorporated 
into cognitive-behavioral therapy (CBT) to 
increase its efficacy. However, such a delay 
may already be a component of CBT, given 
that sessions typically go on for an hour 
or  longer  following  the  initial  exposure 
(i.e., memory reactivation). Foa and Kozak 
(1986) have characterized the mechanism 
behind exposure therapy as the incorpora-
tion of “corrective information.”
Although  the  preclinical  animal  and 
normal  human  studies  are  encouraging, 
the  translational  gap  to  clinical  applica-
tion is huge. Critical differences between 
PTSD and laboratory experiments include 
(in the former) the stronger unconditioned 
  stimulus (US, e.g., a gunshot wound vs. a 
mild electric shock), greater and more sus-
tained arousal at the time of the traumatic 
event (i.e., a stronger unconditioned emo-
tional response), the more complex nature 
of the CS (e.g., a firefight vs. a colored shape), 
the possible presence of multiple condition-
ing events, and the longer duration between 
the memory’s formation and the interven-
tion (e.g., years vs. days). Erasing or updat-
ing the memory of a conditioned response 
acquired 1 day earlier under the influence 
of a mild US might be likened to the effect 
of a firecracker, whereas achieving the same 
for a deeply engraved traumatic memory of 
a life-threatening event in PTSD might be 
likened to the effect of an atomic bomb. It 
remains to be seen whether such a device 
can be constructed.
Lang (1985) proposed that emotion is 
defined by a specific information structure 
in memory, whose content consists of three 
primary categories: (1) information about 
prompting external stimuli and the context 
in  which  they  occur  (stimulus  proposi-
tions); (2) information about responding 
in this context, including expressive ver-
bal behavior, overt acts, and the visceral 
and somatic events that mediate arousal 
and  action  (response  propositions);  and 
(3) information that defines the meaning 
of the stimulus and response data (mean-
ing propositions). These propositions are 
organized  into  an  associative  network 
which, when a critical number of proposi-
tions are accessed, is processed as a unit. We 
suggested that PTSD consists of one or more 
traumatic  emotion  networks  that,  when 
activated, produce its characteristic symp-
tomatology  (Pitman,  1988;  Pitman  and 
Orr, 1990). If a PTSD associative network 
could be reactivated in its entirety, and then 
have its reconsolidation blocked in entirety, 
this  could  simplify  clinical  application. 
Unfortunately research with second-order 
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may be required, in addition to subsequent 
pharmacological blockade of reconsolida-
tion, or behavioral updating, once destabili-
zation has occurred. This suggests a second 
possible, and different, application of DCS 
to PTSD therapy, in addition to its possi-
ble role in the strengthening of extinction 
retention (Cukor et al., 2009).
The  only  published  reconsolidation 
blockade-like study in PTSD to date did 
succeed in producing evidence that pro-
pranolol administered at the time of trau-
matic  memory  reactivation  diminished 
the  memory’s  emotional  component,  as 
manifest  in  smaller  psychophysiological 
responses during subsequent script-driven 
traumatic  imagery  (Brunet  et  al.,  2008). 
However, this study lacked sufficient con-
trols to permit the inference that recon-
solidation  blockade  was  the  underlying 
mechanism.  Moreover,  these  results  are 
preliminary, and many additional studies 
will be required to determine whether the 
therapeutic  promise  of  reconsolidation 
blockade or modification will be fulfilled.
Finally, there is no reason to assume that 
if the therapeutic PTSD bomb can eventu-
ally be constructed, its ultimate ingredient 
will be propranolol. In unpublished research 
with rats, we have found that the glucocor-
ticoid  receptor  antagonist  mifepristone, 
in addition to blocking reconsolidation of 
inhibitory avoidance learning (Taubenfeld 
et  al.,  2009),  has  substantially  stronger 
cue-induced-fear reconsolidation-blocking 
properties than propranolol. This drug has 
yet to be tested in human reconsolidation 
experiments. Other drugs may exist that 
are stronger still. However, for any drug to 
be clinically useful, it must be approved for 
human use and capable of systemic admin-
istration. Moreover, the efficacy of any drug 
has yet to be compared with the efficacy of 
behavioral memory updating techniques. 
All these questions and more will need to be 
addressed within a large research and devel-
opment Manhattan project for PTSD. The 
translation from preclinical work to clinical 
application may prove long and difficult, 
and even unsuccessful. However, given the 
importance of PTSD as a public mental 
health problem, it is worth pursuing.
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